IRIS
POMELLA, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 240
AS - Asia 212
EU - Europa 171
OC - Oceania 1
Totale 624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 239
SG - Singapore 199
IT - Italia 88
IE - Irlanda 27
RU - Federazione Russa 12
GB - Regno Unito 11
DE - Germania 10
FR - Francia 10
CN - Cina 6
FI - Finlandia 5
IN - India 3
GR - Grecia 2
HK - Hong Kong 2
IR - Iran 2
LV - Lettonia 2
AU - Australia 1
CA - Canada 1
EE - Estonia 1
PL - Polonia 1
RS - Serbia 1
SE - Svezia 1
Totale 624
Salva come PNG Salva come JPEG
Città #
Singapore 182
New York 53
Santa Clara 38
Rome 29
Dublin 27
Moscow 11
Mülheim 8
Center 7
London 7
Ashburn 5
Ayn 5
Council Bluffs 5
Colorado Springs 4
Foggia 4
Lappeenranta 4
Bari 3
Palermo 3
Pune 3
Ardea 2
Beijing 2
Bitonto 2
Columbus 2
Gaeta 2
Guilford 2
Hong Kong 2
Kilburn 2
Los Angeles 2
Magenta 2
Mompeo 2
Paris 2
Pontedera 2
Rasht 2
Riga 2
Roseto degli Abruzzi 2
Salt Lake City 2
Shenzhen 2
Washington 2
Belgrade 1
Buffalo 1
Chiswick 1
Dallas 1
Gunzenhausen 1
Helsinki 1
Houston 1
Las Vegas 1
Milan 1
Nuremberg 1
Piraeus 1
Pittsburgh 1
Prescot 1
Santa Maria a Vico 1
Stockholm 1
Tallinn 1
Tempe 1
Trieste 1
Warsaw 1
Totale 455
Salva come PNG Salva come JPEG
Nome #
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 43
Radioresistance in rhabdomyosarcomas: much more than a question of dose 41
Epigenetic remodelling in human hepatocellular carcinoma 33
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas 32
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 31
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 29
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma 29
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 27
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 24
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 24
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 23
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 22
SNAI2-mediated repression of BIM protects rhabdomyosarcoma from ionizing radiation 22
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview 22
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma 21
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma 19
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting 19
New Insights on the Nuclear Functions and Targeting of FAK in Cancer 19
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects 19
FAK Signaling in Rhabdomyosarcoma 18
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression 18
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 18
Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery 18
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma 17
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 15
The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas 14
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 13
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma 12
Chemical genomics reveals histone deacetylases are required for core regulatory transcription 12
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma 12
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 12
KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma 12
Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage 11
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor 11
Design of First-in-Class Dual {EZH}2/{HDAC} Inhibitor: biochemical activity and biological evaluation in cancer cells 10
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges 10
PAX3-FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability 10
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells 10
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 5
Totale 757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023219 0 0 4 1 0 1 129 11 8 28 31 6
2023/2024144 4 2 6 4 10 52 23 5 7 3 2 26
2024/2025394 21 215 146 12 0 0 0 0 0 0 0 0
Totale 757